[1] 王聪,周小波,寇双庆.氯吡格雷150 mg与三联抗血小板对急性前壁心肌梗死PCI患者的疗效比较[J].中国生化药物杂志,2015,35 (7):73-75. [2] 简冬冬,高传玉,李牧蔚.磺达肝癸钠与依诺肝素在中国人急性冠脉综合征PCI术后疗效及安全性的前瞻性研究[J].实用医学杂志,2014,30(5):812-815. [3] Roy P,Buch AN,Javaid A,et al.Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention[J].Am J Cardiol,2008,101(3):293-299.[4] Mehta SK,Frutkin AD,Lindsey JB,et al.Bleeding in patients undergoing percutaneous coronary intervention:the development of a clinical risk algorithm from the National Cardiovascular Data Registry[J].Circ Cardiovasc Interv,2009,2(3):222-229. [5] Kinnaird TD,Stabile E,Mintz GS,et al.Incidence,predictors,and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions[J].Am J Cardiol,2003,92(8):930-935. [6] Manoukian SV,Feit F,Mehran R,et al.Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes:an analysis from the ACUITY Trial[J].J Am Coll Cardiol,2007,49(12):1362-1368. [7] 王纪文,曲鹏,魏国峰.磺达肝癸钠在不稳定型心绞痛患者pci围手术期应用的临床观察[J].大连医科大学学报,2012,34(6):598-600. [8] 何昕,张翼,罗海波,等.盐酸替罗非班对急性ST段抬高型心肌梗死急诊pci术后再灌注的影响[J].医学临床研究,2008,25(8):1406-1408. [9] Iba T,Okamoto K,Ohike T,et al.Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats[J].J Trauma Acute Care Surg,2012,72(1):177-182.
2018, Vol. 35 
